|
1. STUDY OF MECHANISMS ACTION OF FULLERENE ON SYSTEM OF CELL'S ION TRANSPORT WITH PURPOSE OF THE DEVELOPMENT OF PATHOGENICALLY REASONABLE THERAPY OF CARDIOVASCULAR DISEASE. Technical report for 1995-1997, #0195U009084 of IT UAMS for Ukrainian Academy of Medical Sciences, Kharkov, 1997, 44 p. (in Russian).
2. DEVELOPMENT OF NEW APPROACHES TO THE PATHOGENIC CORRECTION OF THE ARTERIAL HYPERTENSION ON THE BASE OF THE FULLERENES INTERACTIONS WITH COMPONENTS OF THE CELL MEMBRANES, THE SYSTEMS OF THE SECONDARY MESSENGERS, THE VASOPEPTIDES AND THE METABOLITES OF ARACHODONIC ACID. Technical report for 1998-2000, #0198U002557 of IT UAMS for Ukrainian Academy of Medical Sciences, Kharkov, 2000, 36 p. (in Russian).
3. DETERMINATION OF THE PROBABLE VASOPROTECTIVE AND ANTIATHEROGENIC EFFECTS OF STABLE COLLOIDAL SOLUTIONS OF CHEMICALLY NON-MODIFICATED FULLERENES. Technical report for 2001-2003, #0101U000151, F05/01 of IT UAMS for Ukrainian Academy of Medical Sciences, Kharkov, 2003, 57 p.(in Ukrainian).
4. COMPARATIVE INVESTIGATION OF THE IMMUNOGENIC PROPERTIES OF WATER SOLUTIONS OF HYDRATED FULLERENE C60 (С60FWS); Laboratory Report of the SSC RU “Institute of Immunology” MH RU, Moscow, Russia, 2002, 11 p.
5. INVESTIGATION OF THE SPECIFIC ACTIVITY AND TOXIC ACTION OF WATER SOLUTION OF HYDRATED С60 FULLERENE (C60FWS). Report of the Laboratory of Morphofunctional Research, National Pharmaceutical University MHU, Kharkov, Ukraine, 2009, 68 p., (Abstract).
6. TRIALS OF RADIOPROTECTIVE INFLUENCE OF WATER SOLUTION OF HYDRATED FULLERENE С60 (C60FWS) IN THE EXPERIMENT ON RATS. Report of the Laboratory of Radioprotective Drugs, State Institute of Medical Radiology AMSU, Kharkov, Ukraine, 2009, 17 p.
7. EFFICACY OF FULLERENE (C60) APPLICATION IN COMPLEX THERAPY OF PATIENTS WITH ULCERATIVE DISEASE. Report of the 3-nd Department of Internal Medicine, Kharkov National Medical University, Kharkov, Ukraine, 2009, 33 с., (Abstract).
8. EFFICACY OF APPLICATION OF BIOLOGICALLY ACTIVE SUPPLEMENT “WATER SOLUTION OF HYDRATED С60 FULLERENE” IN COMPLEX THERAPY OF PATIENTS WITH CHRONIC HEPATITIS OF TOXIC GENESIS. Report of the 3-nd Department of Internal Medicine, Kharkov National Medical University, Kharkov, Ukraine, 2009, 37 p., (Abstract).
9. INVESTIGATION OF TOXICOLOGICAL CHARACTERISTICS OF HYDRATED C60 FULLERENE NANOPARTICLES ON EUKARIOTIC CELLS ON THE BASIS OF DATA ABOUT THEIR CYTOTOXICITY, PROINFLAMMATORY ACTIVITY. Report (interim) of the Gamalei SRI EM AMS RU, Moscow, Russia, 2010, 6 p. (in Russ)
10. ANALYTICAL REPORT AS FOR THE ESTIMATION OF THE HAZARD DEGREE OF HYDRATED C60 FULLERENE (C60HyFn) FOR HUMAN HEALTH. "Institute of Physiological Active Compounds" LLC, Kharkov, Ukraine, 2010, 12 p. (in Russ).
11. STUDY OF THE PROBABLE GENOTOXIC ACTION OF HYDRATED C60 FULLERENE (C60HyFn) IN THE FORM OF IT WATER SOLUTION (C60FWS). Report of the Laboratory of Radiation Cytogenetics, State Institute of Medical Radiology AMSU, Kharkov, Ukraine, 2010, 19 p. (in Russ).
|